- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Herantis Pharma Oyj (HRTIS)
Herantis Pharma Oyj stock price live, this page displays HE HRTIS stock exchange data. View the HRTIS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Herantis Pharma Oyj real time stock price chart below.
What Is the Herantis Pharma Oyj Stock Price Today?
The Herantis Pharma Oyj stock price today is 2.130.
What Is the Stock Symbol for Herantis Pharma Oyj?
The stock symbol for Herantis Pharma Oyj is ""HRTIS.""
What Stock Exchange Does Herantis Pharma Oyj Trade On?
Herantis Pharma Oyj is listed and trades on the Helsinki stock exchange.
Is Herantis Pharma Oyj a Good Stock to Buy?
Determining whether Herantis Pharma Oyj—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HRTIS quote. (ISIN: FI4000087861)
What Is the Herantis Pharma Oyj Stock Price Today?
The Herantis Pharma Oyj stock price today is 2.130.
What Is the Stock Symbol for Herantis Pharma Oyj?
The stock symbol for Herantis Pharma Oyj is ""HRTIS.""
What Stock Exchange Does Herantis Pharma Oyj Trade On?
Herantis Pharma Oyj is listed and trades on the Helsinki stock exchange.
Is Herantis Pharma Oyj a Good Stock to Buy?
Determining whether Herantis Pharma Oyj—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HRTIS quote. (ISIN: FI4000087861)
Helsinki
Currency in EUR
2.130
+0.040(+1.91%)
Real-time Data·
Fair Value
An estimate of a Herantis Pharma Oyj's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.090
2.230
52 wk Range
1.180
3.870
HRTIS Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
HRTIS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Herantis Pharma Oyj's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.0902.230
52 wk Range
1.1803.870
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HRTIS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Herantis Pharma Oyj's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
2.500
Upside
+17.37%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Herantis Pharma Oyj Company Profile
Herantis Pharma Oyj, a clinical stage biotechnology company, engages in the development of disease-modifying cerebral dopamine neurotrophic factor (CDNF) based therapies for Parkinson’s disease (PD). The company’s lead product in pipeline includes HER-096, an advanced small synthetic chemical peptidomimetic molecule developed based on the active site of the CDNF protein that is in phase 1b clinical trial for the treatment of PD and other neurodegenerative diseases. The company was incorporated in 2008 and is based in Espoo, Finland.
Compare HRTIS to Peers and Sector
Metrics to compare | HRTIS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHRTISPeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.2x | −2.0x | −0.7x | |
PEG Ratio | 0.01 | 0.02 | 0.00 | |
Price/Book | 28.8x | −0.1x | 2.6x | |
Price / LTM Sales | - | 26.9x | 3.4x | |
Upside (Analyst Target) | 17.9% | 100.5% | 37.8% | |
Fair Value Upside | Unlock | −1.8% | 5.5% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 2.500
(+17.37% Upside)
Earnings
Latest Release
Aug 21, 2025
EPS / Forecast
-0.1278 / -0.1844
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Herantis Pharma Oyj Trade On?
Herantis Pharma Oyj is listed and trades on the Helsinki Stock Exchange stock exchange.
What Is the Stock Symbol for Herantis Pharma Oyj?
The stock symbol for Herantis Pharma Oyj is "HRTIS."
What Is the Herantis Pharma Oyj Market Cap?
As of today, Herantis Pharma Oyj market cap is 51.32M.
What Is Herantis Pharma Oyj's Earnings Per Share (TTM)?
The Herantis Pharma Oyj EPS (TTM) is -0.25.
When Is the Next Herantis Pharma Oyj Earnings Date?
Herantis Pharma Oyj will release its next earnings report on 02 Dec 2025.
From a Technical Analysis Perspective, Is HRTIS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Herantis Pharma Oyj Stock Split?
Herantis Pharma Oyj has split 0 times.
How Many Employees Does Herantis Pharma Oyj Have?
Herantis Pharma Oyj has 13 employees.
What is the current trading status of Herantis Pharma Oyj (HRTIS)?
As of 14 Oct 2025, Herantis Pharma Oyj (HRTIS) is trading at a price of 2.130, with a previous close of 2.09. The stock has fluctuated within a day range of 2.090 to 2.230, while its 52-week range spans from 1.180 to 3.870.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.